Sionna stock

Sionna Stock

HealthTech
Founded: 2019Funding to Date: $331Mhttps://www.sionnatx.com

Sionna is a life sciences technology developer focused on creating highly effective and distinct treatments for cystic fibrosis. The company is advancing first-in-class small molecules targeting a unique pathway, aiming to fully normalize cystic fibrosis transmembrane conductance regulator (CFTR) function for the vast majority of those affected by the condition. Sionna's approach promises best-in-class efficacy, broad reach, and sustained benefits for cystic fibrosis patients.

Investors Include:

Qatar Investment Authority, Enavate Sciences, Viking Global Investors, Atlas Venture, Perceptive Advisors, OrbiMed, AbbVie Ventures, TPG, T. Rowe Price Group, RA Capital Management, Cystic Fibrosis Foundation.

Own Sionna stock or options?

Get an instant valuation

  • Completely free
  • 100% confidential & secure
  • Takes less than a minute
100% private & secure

Management Team

Mark Namchuk Ph.DScientific Advisor
Mike CloonanChief Executive Officer, President & Board Member
Elena RidloffChief Financial Officer & Head of Corporate Development
Vanya SagarChief People Officer
Charlotte McKee MDChief Medical Officer
John Lowe Ph.DScientific Advisor
Greg Hurlbut Ph.DCo-Founder & Senior Vice President of Discovery Research
Mark Munson Ph.DCo-Founder and Vice President of Medicinal Chemistry
Patrick Flume MDClinical Advisor
Michael Konstan MDClinical Advisor
Taiyin Yang Ph.DScientific Advisor
Bonnie Ramsey MDClinical Advisor

Board Members

Bruce Booth Ph.DBoard Member
Lucian Iancovici MDBoard Member
Edward Fleming MDBoard Member

Sionna’s stock FAQs

Other HealthTech Companies in Collective's mid-stage Target Portfolio.

A2 Bio stock
Aardvark Therapeutics stock
AcuityMD stock
Alamar Biosciences stock
Alterome Therapeutics stock
Arbor Biotechnologies stock
Attralus stock
Be Biopharma stock
Bluejay Therapeutics stock
Brightside Health stock
Capstan Therapeutics stock
Carrum Health stock
Casana stock
Cellanome stock
Centivo stock
Chroma Medicine stock
Conformal stock
Convergent Therapeutics stock
Covera Health stock
Detect stock
Dewpoint Therapeutics stock
Dispatch Biotherapeutics stock
Egenesis stock
Elektrofi stock
Engrail Therapeutics stock
Equip stock
Firefly Health stock
Flare Therapeutics stock
Florence stock
FogPharma stock
Foresight Mental Health stock
Frontier Medicines stock
Genesis Therapeutics stock
Graviton BioScience stock
Hexagon Bio stock
Iambic Therapeutics stock
IDRx stock
Inceptive stock
Infinitus Systems stock
KSQ stock
Levels stock
LifeMine stock
LightForce stock
Loyal stock
Luna Physical Therapy stock
Lycia Therapeutics stock
Marea stock
Medallion stock
Nalu Medical stock
Neuron23 stock
NextPoint stock
OrsoBio stock
Ossium Health stock
Ostro stock
Overjet stock
Pager stock
Paradigm stock
Paradromics stock
Pathalys Pharma stock
Pelago stock
Pomelo Care stock
Rad AI stock
ReCode Therapeutics stock
Regard stock
Rivus Pharmaceuticals stock
Route 92 stock
SalioGen Therapeutics stock
Santa Ana Bio stock
Seismic Therapeutic stock
SmarterDx stock
SmithRx stock
Strand Therapeutics stock
Suki stock
Syllable stock
Synchron stock
Synthekine stock
Third Arc Bio stock
Tome Biosciences stock
Tomorrow Health stock
Triveni Bio stock
Two Chairs stock
Unlearn stock
Vanqua Bio stock
Verse Medical stock
Viome Life Sciences stock
Vizgen stock